This is due to the nature of AhR signaling in skin: patients with AD have dominant non-canonical AhR signaling that is pathologic, so AhR agonists are helpful for restoring the balance between canonical and non-canonical pathways in these patients [29]. The gene discussed is AHR; the disease is Alzheimer disease.